PI Industries Share Price Crashes 15% to 6-Year Low After Q2 Results; Profit Plunges 70%
PI Industries shares touched an intraday low of Rs. 1,859.25 on the BSE, falling below their previous low of Rs. 2,006 recorded on October 27th. The stock was trading at its lowest level since September 2020. The stock had declined approximately 41.6% over the past year. At ar...
Key Market Intelligence & Spot Updates
PI Industries shares touched an intraday low of Rs. 1,859.25 on the BSE, falling below their previous low of Rs. 2,006 recorded on October 27th. The stock was trading at its lowest level since September 2020. The stock had declined approximately 41.6% over the past year.
At around 12:30 PM, PI Industries shares were down 15.72% at Rs. 1,843.10 on the BSE, while the Sensex was up approximately 2%.
Trading activity also intensified, with volumes nearly doubling as around 2.18 million shares changed hands across the NSE and BSE.
The stock has now lost more than half its value from its 52-week high of Rs. 3,829, recorded IN November 2025.
- Benchmark Quote #1:Reported trading price point of Rs. 1,859.25 across retail jeweler networks.
- Benchmark Quote #2:Reported trading price point of Rs. 2,006 across retail jeweler networks.
- Benchmark Quote #3:Reported trading price point of Rs. 1,843.10 across retail jeweler networks.
- Benchmark Quote #4:Reported trading price point of Rs. 3,829, across retail jeweler networks.
PI Industries Q2 FY27 Results
PI Industries reported a disappointing performance for the second quarter of FY27,, with revenue declining 9% year-on-year to Rs. 1,702 crore. EBITDA fell sharply by 57% to Rs. 232.7 crore, while the EBITDA margin contracted by 1,524 basis points to 13.7%. The company's profit after tax (PAT) plunged 70% year-on-year to Rs. 122 crore.
ICICI Securities on PI Industries
ICICI Securities described PI Industries' Q2 FY27 performance as disappointing, due to weak agrochemical exports amid subdued global demand.
According to the brokerage, genericisation, pricing pressure and cost escalation were not being actively passed through, further affecting profitability.
Meanwhile, PI Industries' domestic agricultural biologicals business recorded growth of more than 45%. The company has also onboarded large pharmaceutical customers and is working on two strategic products aimed at securing long-term contracts.
Despite the weak quarterly performance, PI Industries reported a cash balance of Rs. 3,573 crore and incurred capital expenditure of Rs. 567 crore during the first half of FY27.